Deutsche Bank’s Xenetic Biosciences XBIO Stock Holding History

Deutsche Bank’s Portfolio XBIO Stock Details XBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,544	Closed	-$36K	–	4878
2019 Q4	$36K	Buy	+2,544	New	+$32.3K	﹤0.01%	4093
2018 Q4	–	Sell	-1	Closed	–	–	5446
2018 Q3	$0	Buy	+1	New	+$390	﹤0.01%	5581
2018 Q2	–	Sell	-20	Closed	-$5K	–	5645
2018 Q1	$5K	Sell	20 -1	-5%	-$251	﹤0.01%	5243
2017 Q4	$4K	Buy	+21	New	+$5.95K	﹤0.01%	4880
2017 Q2	–	Hold	0	–	–	–	5141
2017 Q1	–	Hold	0	–	–	–	5123

Other funds holding XBIO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Deutsche Bank's XBIO Position: Q1 2020 in Review

Deutsche Bank sold out of Xenetic Biosciences (XBIO) in Q1 2020, closing a stake of 2,544 shares — an estimated $36K sold.

Deutsche Bank first reported a position in XBIO in Q4 2017 and held it in 4 quarters. The position peaked at $36K in Q4 2019. 8 funds tracked by Wall St. Rank hold XBIO as of Q1 2020.

Deutsche Bank reported no remaining Xenetic Biosciences position as of Q1 2020 after selling out during the quarter.
Deutsche Bank sold 2,544 Xenetic Biosciences shares in Q1 2020, an estimated $36K.
Deutsche Bank first reported a position in Xenetic Biosciences in Q4 2017 and held it in 4 quarters.
Deutsche Bank's Xenetic Biosciences position peaked at $36K in Q4 2019.
8 funds tracked by Wall St. Rank held Xenetic Biosciences as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.